Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects
about
ICP0 antagonizes ICP4-dependent silencing of the herpes simplex virus ICP0 genePML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0TRIM family proteins: retroviral restriction and antiviral defenceEpstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expressionAbility of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cellsHerpes simplex virus 1 induces cytoplasmic accumulation of TIA-1/TIAR and both synthesis and cytoplasmic accumulation of tristetraprolin, two cellular proteins that bind and destabilize AU-rich RNAsFormation of nuclear foci of the herpes simplex virus type 1 regulatory protein ICP4 at early times of infection: localization, dynamics, recruitment of ICP27, and evidence for the de novo induction of ND10-like complexesThe herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genesHerpes simplex virus-infected cell protein 0 blocks the silencing of viral DNA by dissociating histone deacetylases from the CoREST-REST complexThe degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5aMacrophages and cytokines in the early defence against herpes simplex virusRole of ND10 nuclear bodies in the chromatin repression of HSV-1Infected cell protein 0 functional domains and their coordination in herpes simplex virus replicationThe Role of Nuclear Antiviral Factors against Invading DNA Viruses: The Immediate Fate of Incoming Viral GenomesEmerging Role of PML Nuclear Bodies in Innate Immune SignalingHSV-1 ICP0: paving the way for viral replicationCellular promyelocytic leukemia protein is an important dengue virus restriction factorState and role of SRC family kinases in replication of herpes simplex virus 1.Herpes simplex virus 1 infected cell protein 0 forms a complex with CIN85 and Cbl and mediates the degradation of EGF receptor from cell surfaces.Immune Escape via a Transient Gene Expression Program Enables Productive Replication of a Latent Pathogen.A role for cytoplasmic PML in cellular resistance to viral infectionMurine gammaherpesvirus 68 ORF75c contains ubiquitin E3 ligase activity and requires PML SUMOylation but not other known cellular PML regulators, CK2 and E6AP, to mediate PML degradationThe carboxy terminal region of the human cytomegalovirus immediate early 1 (IE1) protein disrupts type II inteferon signaling.The stability of herpes simplex virus 1 ICP0 early after infection is defined by the RING finger and the UL13 protein kinase.The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primatesElimination of ie1 significantly attenuates murine cytomegalovirus virulence but does not alter replicative capacity in cell cultureEntrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus.Novel roles of cytoplasmic ICP0: proteasome-independent functions of the RING finger are required to block interferon-stimulated gene production but not to promote viral replication.Disruption of PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required for varicella-zoster virus pathogenesis in skin.Interwoven roles of cyclin D3 and cdk4 recruited by ICP0 and ICP4 in the expression of herpes simplex virus genesAdenovirus protein IX sequesters host-cell promyelocytic leukaemia protein and contributes to efficient viral proliferation.Regulation of Sp100A subnuclear localization and transcriptional function by EBNA-LP and interferon.Postinternalization inhibition of adenovirus gene expression and infectious virus production in human T-cell linesSpatial and temporal organization of adeno-associated virus DNA replication in live cells.ICP0 and the US3 protein kinase of herpes simplex virus 1 independently block histone deacetylation to enable gene expression.A Phospho-SIM in the Antiviral Protein PML is Required for Its Recruitment to HSV-1 Genomes.Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia/Lassa reassortant 29 (ML29), a vaccine candidateICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency.Herpes simplex virus 1 precludes replenishment of the short-lived receptor of tumor necrosis factor alpha by virion host shutoff-dependent degradation of its mRNA.Nuclear domain 10 of the viral aspect.
P2860
Q21562602-2B1374A7-2E87-4187-8AF1-B1DF9B7708A6Q24298207-7F5E7ECC-6BA3-4590-8CF7-B3A7811D5F41Q24329175-D2502EC0-C4A7-4C4D-90E6-F66FE38A949BQ24562972-3FBBCFE2-3C29-4115-BE4C-02011A53FEEAQ24563268-28445124-EE73-48A3-8723-A4331DB7BAFBQ24563981-4F46145B-2FC3-4613-AF7A-1A9789EFBD42Q24607261-FB3DABAD-E2D0-4F19-AF5C-771FC09A70C3Q24607496-07952CC5-E0DF-4328-BED8-41DEB7182402Q24675640-407DB6C8-FD00-46D1-9987-7AF391C11F36Q24678629-E1B54668-7D6B-4F0B-9115-931E00625B95Q24815062-C0D6665D-CF30-45D1-B3B9-8FFF471600D0Q26751443-B9D0F5A0-1EDB-4A97-AD91-2CC9D93E9756Q26766356-754C926F-09B2-42E5-B363-21619DF06DD0Q28071373-F030DB4C-61CC-4891-8970-538DC40685E5Q28075721-F16B2154-4B66-4BE2-B9B5-B099DC06AB60Q28243426-03416B21-8786-428D-9DEB-27DB7D099D91Q28547173-66629B84-2AF2-4D51-9C41-6E73F84C9AB0Q30159875-D83890A3-CC0C-4F30-B648-9B7B404B4E31Q30160269-3F391161-B745-4140-B464-B0B312B7EE65Q30840932-5094D9A6-CF6D-43D6-A1CB-EB5071E04D82Q33338503-D2C5E33B-668E-4FE3-B38B-63462C5E4147Q33575096-D1918279-475D-438D-A9C5-60887574B16FQ33584744-D4CC9F0D-B893-4759-A9D9-44439829F69BQ33602881-11DA4DCC-4CC0-4559-9CEA-C5E0C79DEBE2Q33780572-44E81955-1632-4D47-89A1-8F194D48D562Q33788669-C07C9F3E-9E3A-459A-8B8E-D5D51D48B1E2Q33815559-BCD3A35B-74DF-4E9B-8C85-4BD023A7690FQ33900347-05F00AD4-6B9B-4C89-B794-B60DF219D622Q34013598-6F33FB0F-8D84-4C77-BAEE-2F30CBDFB217Q34120752-767D2FE9-7987-4C69-B05B-D0AC6BC7970DQ34250538-579573C8-3548-43E6-A336-C771E8033BF6Q34334212-D7E52E4B-5878-4302-A689-16BC1C6D6D88Q34436727-06DE6D85-EEFB-44AF-8792-1805E4BE8092Q34554366-813E641D-ECE6-4FB4-AE68-8FDBD6B9D6B7Q34773141-0F0E0214-1740-43BE-A2A5-22EC60A6E92AQ34774721-1627F924-DD3A-4E4C-9FE7-E36C23E11FF3Q34999818-B34AA2E6-E32B-4817-B37A-A262F64A4BC2Q35013167-9A4FEF3B-5722-4182-A76A-B86CCA99CD9EQ35023681-EDFC78BC-F867-421C-AB37-FACC611580C7Q35047491-94784733-CFB0-403F-8954-FFA718EB91B5
P2860
Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Promyelocytic leukemia protein ...... herpes simplex virus 1 effects
@ast
Promyelocytic leukemia protein ...... herpes simplex virus 1 effects
@en
type
label
Promyelocytic leukemia protein ...... herpes simplex virus 1 effects
@ast
Promyelocytic leukemia protein ...... herpes simplex virus 1 effects
@en
prefLabel
Promyelocytic leukemia protein ...... herpes simplex virus 1 effects
@ast
Promyelocytic leukemia protein ...... herpes simplex virus 1 effects
@en
P2860
P1433
P1476
Promyelocytic leukemia protein ...... herpes simplex virus 1 effects
@en
P2093
Ana V Chee
Pascal Lopez
P2860
P304
P356
10.1128/JVI.77.12.7101-7105.2003
P407
P577
2003-06-01T00:00:00Z